Fine Grain Structure We3 Series Tungsten Electrode for Precision Applications

Name: Fine Grain Structure We3 Series Tungsten Electrode for Precision Applications
Brand: Hainan Chenxiang New Materials Technology Co., Ltd.
SKU: 2117504552

Shandong, ChinaHainan Chenxiang New Materials Technology Co., Ltd.

US$12.40-88.00

10 box

Sample price:US$98.00/box.Request sample

Product profile

Customization

Available

Type

Compound Tungsten Electrode

Material

Tungsten

Model NO.

WE3

Diameter

1.0-4.8mm

Length

150/175mm

Function

Non-Consumable Electrode

Added Impurity

Y2o3

Impurity Quantity

1.80-2.20%

Color Code

Purple

Current Type

Standard

Aws A5.12(Ewp)

Transport Package

Carton, Wooden Case

Specification

Dia(1.08*4.8mm)*L(150/175mm)

Trademark

CHENXIANG

Origin

China

HS Code

8515900090

Production Capacity

100ton

Company profile

Hainan Chenxiang New Materials Technology Co., Ltd.

Shandong, China

Business Type: Trading CompanyAverage Response Time: ≤18h

AI-Powered supplier vetting

SummaryThe supplier is identified as a professional technical supplier with engineering and R&D support, broad customization capability, ODM availability, and OEM experience for well-known brands. Its stated business scope includes pharmaceutical excipients, new-material R&D, chemical products, paper products, packaging materials, plastics, and related goods. Production evidence includes a 40,000-square-meter base, advanced manufacturing and testing facilities, and a team of over 50 professionals. However, finished-product inspection is based on random inspection and only one quality assurance/control inspector is reported. The supplier has inventory capability but no overseas warehouse, showroom, agent, or branch. No certifications, formal after-sales service system, or verified customer cases are provided. Innovation evidence is mixed: ODM and engineering support are available, but there were no new products in the past year and no SDK.

Supplier typeThe supplier is explicitly identified as a professional technical supplier. Its stated scope covers pharmaceutical excipients, new-material research and development, chemical products, paper products, packaging materials, plastics, and related goods, indicating a manufacturing and technical-materials orientation.

Financial creditThe reported financial-capacity records for 2024 and the prior two-year period show zero values for the listed operating and profit measures. These figures do not provide positive evidence of financial strength and may indicate a material reporting concern, but the slices do not explain the data or establish insolvency.

R&D capabilityThe supplier reports professional R&D capability, new-material R&D scope, engineering support, ODM service, and a dedicated R&D division within a team of over 50 professionals. Nevertheless, it reported no new products in the past year and no available SDK, so innovation capability is supported mainly by organizational and service claims rather than recent product-output evidence.

Production capacityEvidence includes flexible production, a 40,000-square-meter production base, advanced manufacturing and testing facilities, stock capability, and an off-season average lead time within 15 workdays. Quality-control capacity appears limited by the reported single QA/QC inspector and random finished-product inspection, while the service-capability assessment lacks a written procedure.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, minor customization, and flexible customization. Its descriptions also cite tailored solutions involving composition adjustment, private-label packaging, special-industry product design, and ODM services, providing strong evidence of broad customization capability.